[go: up one dir, main page]

HK1071685B - Pharmaceutical composition comprising an s1p receptor agonist - Google Patents

Pharmaceutical composition comprising an s1p receptor agonist Download PDF

Info

Publication number
HK1071685B
HK1071685B HK05102715.5A HK05102715A HK1071685B HK 1071685 B HK1071685 B HK 1071685B HK 05102715 A HK05102715 A HK 05102715A HK 1071685 B HK1071685 B HK 1071685B
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
receptor agonist
agonist
receptor
pharmaceutical
Prior art date
Application number
HK05102715.5A
Other languages
Chinese (zh)
Other versions
HK1071685A1 (en
Inventor
Oomura Tomoyuki
Pudipeddi Madhusudhan
Ruegger Colleen
Edward Royce Alan
Sasaki Masaki
Tamura Tokuhiro
Original Assignee
Novartis Ag
Mitsubishi Tanabe Pharma Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Mitsubishi Tanabe Pharma Corporation filed Critical Novartis Ag
Publication of HK1071685A1 publication Critical patent/HK1071685A1/en
Publication of HK1071685B publication Critical patent/HK1071685B/en

Links

HK05102715.5A 2003-04-08 2005-03-31 Pharmaceutical composition comprising an s1p receptor agonist HK1071685B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46121503P 2003-04-08 2003-04-08
US60461215 2003-04-08

Publications (2)

Publication Number Publication Date
HK1071685A1 HK1071685A1 (en) 2005-07-29
HK1071685B true HK1071685B (en) 2006-08-04

Family

ID=

Similar Documents

Publication Publication Date Title
HUS1100016I1 (en) Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003268087A1 (en) Liposomal gemcitabine compositions for better drug delivery
AU2003290700A1 (en) Farnesoid x receptor agonists
AU2002350584A1 (en) Dopamine agonist formulations for enhanced central nervous system delivery
AU2003302603A1 (en) Improved opioid pharmaceutical compositions
AU2003244650A1 (en) Arylethanolamine beta2-adrenoreceptor agonist compounds
AU2003291103A1 (en) Pharmaceutical composition
EG24194A (en) 5ht-a-partial agonist pharmaceutical compositions
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2003250372A1 (en) Pharmaceutical composition
AU2003248356A1 (en) Beta3-adrenergic receptor agonists
AU2003272127A1 (en) Polymeric composition for drug delivery
AU2003245033A1 (en) An improved and stable pharmaceutical composition containing substituted benzimidazoles and a process for its preparation
AU2003280065A1 (en) Bupropion hydrochloride solid dosage forms
HK1071685B (en) Pharmaceutical composition comprising an s1p receptor agonist
AUPS188302A0 (en) Pharmaceutical composition
HK1089377A (en) Pharmaceutical composition
HK1088245A (en) Pharmaceutical composition
AU2003902322A0 (en) Pharmaceutical composition
HK1087342A (en) Muscarinic m1 receptor agonists for pain management
HK1092712A (en) Pharmaceutical compositions
HK1092702A (en) Pharmaceutical compositions
HK1097200A (en) Novel pharmaceutical compositions comprising agonists of the thyroid receptor
AU2003904627A0 (en) Pharmaceutical Formulation